Literature DB >> 10097093

Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex.

G Venkataraman1, R Raman, V Sasisekharan, R Sasisekharan.   

Abstract

Fibroblast growth factor (FGF) family plays key roles in development, wound healing, and angiogenesis. Understanding of the molecular nature of interactions of FGFs with their receptors (FGFRs) has been seriously limited by the absence of structural information on FGFR or FGF-FGFR complex. In this study, based on an exhaustive analysis of the primary sequences of the FGF family, we determined that the residues that constitute the primary receptor-binding site of FGF-2 are conserved throughout the FGF family, whereas those of the secondary receptor binding site of FGF-2 are not. We propose that the FGF-FGFR interaction mediated by the 'conserved' primary site interactions is likely to be similar if not identical for the entire FGF family, whereas the 'variable' secondary sites, on both FGF as well as FGFR mediates specificity of a given FGF to a given FGFR isoform. Furthermore, as the pro-inflammatory cytokine interleukin 1 (IL-1) and FGF-2 share the same structural scaffold, we find that the spatial orientation of the primary receptor-binding site of FGF-2 coincides structurally with the IL-1beta receptor-binding site when the two molecules are superimposed. The structural similarities between the IL-1 and the FGF system provided a framework to elucidate molecular principles of FGF-FGFR interactions. In the FGF-FGFR model proposed here, the two domains of a single FGFR wrap around a single FGF-2 molecule such that one domain of FGFR binds to the primary receptor-binding site of the FGF molecule, while the second domain of the same FGFR binds to the secondary receptor-binding site of the same FGF molecule. Finally, the proposed model is able to accommodate not only heparin-like glycosaminoglycan (HLGAG) interactions with FGF and FGFR but also FGF dimerization or oligomerization mediated by HLGAG.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10097093      PMCID: PMC22350          DOI: 10.1073/pnas.96.7.3658

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Amino acid substitution matrices from protein blocks.

Authors:  S Henikoff; J G Henikoff
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

2.  Fibroblast growth factor (FGF) homologous factors: new members of the FGF family implicated in nervous system development.

Authors:  P M Smallwood; I Munoz-Sanjuan; P Tong; J P Macke; S H Hendry; D J Gilbert; N G Copeland; N A Jenkins; J Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

Review 3.  The coordinated regulation of heparan sulfate, syndecans and cell behavior.

Authors:  A C Rapraeger
Journal:  Curr Opin Cell Biol       Date:  1993-10       Impact factor: 8.382

4.  On global sequence alignment.

Authors:  X Huang
Journal:  Comput Appl Biosci       Date:  1994-06

5.  A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist.

Authors:  H Schreuder; C Tardif; S Trump-Kallmeyer; A Soffientini; E Sarubbi; A Akeson; T Bowlin; S Yanofsky; R W Barrett
Journal:  Nature       Date:  1997-03-13       Impact factor: 49.962

6.  aFGF binding to low and high affinity receptors induces both aFGF and aFGF receptors dimerization.

Authors:  F Mascarelli; G Fuhrmann; Y Courtois
Journal:  Growth Factors       Date:  1993       Impact factor: 2.511

7.  Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta.

Authors:  J D Zhang; L S Cousens; P J Barr; S R Sprang
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

8.  Preferential self-association of basic fibroblast growth factor is stabilized by heparin during receptor dimerization and activation.

Authors:  G Venkataraman; V Sasisekharan; A B Herr; D M Ornitz; G Waksman; C L Cooney; R Langer; R Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

9.  Alternately spliced NH2-terminal immunoglobulin-like Loop I in the ectodomain of the fibroblast growth factor (FGF) receptor 1 lowers affinity for both heparin and FGF-1.

Authors:  F Wang; M Kan; G Yan; J Xu; W L McKeehan
Journal:  J Biol Chem       Date:  1995-04-28       Impact factor: 5.157

10.  Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation.

Authors:  T Spivak-Kroizman; M A Lemmon; I Dikic; J E Ladbury; D Pinchasi; J Huang; M Jaye; G Crumley; J Schlessinger; I Lax
Journal:  Cell       Date:  1994-12-16       Impact factor: 41.582

View more
  18 in total

1.  Identification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor.

Authors:  C Hundt; J M Peyrin; S Haïk; S Gauczynski; C Leucht; R Rieger; M L Riley; J P Deslys; D Dormont; C I Lasmézas; S Weiss
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

2.  Heparin sequencing brings structure to the function of complex oligosaccharides.

Authors:  M A Nugent
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

Review 3.  An inductive signalling network regulates mammalian tooth morphogenesis with implications for tooth regeneration.

Authors:  Z Li; M Yu; W Tian
Journal:  Cell Prolif       Date:  2013-08-17       Impact factor: 6.831

Review 4.  Nanoscale materials for probing the biological functions of the glycocalyx.

Authors:  Mia L Huang; Kamil Godula
Journal:  Glycobiology       Date:  2016-02-24       Impact factor: 4.313

Review 5.  Secretion without Golgi.

Authors:  Igor Prudovsky; Francesca Tarantini; Matteo Landriscina; David Neivandt; Raffaella Soldi; Aleksandr Kirov; Deena Small; Karuppanan Muthusamy Kathir; Dakshinamurthy Rajalingam; Thallapuranam Krishnaswamy Suresh Kumar
Journal:  J Cell Biochem       Date:  2008-04-01       Impact factor: 4.429

6.  Biophysical constraints on the evolution of tissue structure and function.

Authors:  P J Hunter; B de Bono
Journal:  J Physiol       Date:  2014-06-01       Impact factor: 5.182

7.  Oncologic Angiogenesis Imaging in the clinic---how and why.

Authors:  Karen A Kurdziel; Liza Lindenberg; Peter L Choyke
Journal:  Imaging Med       Date:  2011-09

8.  Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome.

Authors:  O A Ibrahimi; A V Eliseenkova; A N Plotnikov; K Yu; D M Ornitz; M Mohammadi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

9.  Syndromic congenital sensorineural deafness, microtia and microdontia resulting from a novel homoallelic mutation in fibroblast growth factor 3 (FGF3).

Authors:  Osama Alsmadi; Brian F Meyer; Fowzan Alkuraya; Salma Wakil; Fadi Alkayal; Haya Al-Saud; Khushnooda Ramzan; MoeenAldeen Al-Sayed
Journal:  Eur J Hum Genet       Date:  2008-08-13       Impact factor: 4.246

Review 10.  Therapeutic angiogenesis: controlled delivery of angiogenic factors.

Authors:  Hunghao Chu; Yadong Wang
Journal:  Ther Deliv       Date:  2012-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.